Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.

OBJECTIVE: To evaluate the efficacy and safety of galantamine in the treatment of Alzheimer's disease. DESIGN: Randomised, double blind, parallel group, placebo controlled trial. SETTING: 86 outpatient clinics in Europe and Canada. PARTICIPANTS: 653 patients with mild to moderate Alzheimer...

Full description

Bibliographic Details
Main Authors:	Wilcock, G, Lilienfeld, S, Gaens, E
Format:	Journal article
Language:	English
Published:	2000

Similar Items

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial (vol 321, pg 1445, 2000)
by: Wilcock, G
Published: (2001)

Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial.
by: Pirttilä, T, et al.
Published: (2004)

Erratum: Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: Multicentre randomised controlled trial (British Medical Journal (December 9) (1445-1449))
by: Wilcock, G
Published: (2001)

Erratum: Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: Multicentre randomised controlled trial (British Medical Journal (December 9)(1445-1449))
by: Wilcock, G
Published: (2001)

Galantamine in Alzheimer's disease.
by: Razay, G, et al.
Published: (2008)

Safety and efficacy of galantamine in subjects with mild cognitive impairment.
by: Winblad, B, et al.
Published: (2008)

A long-term comparison of galantamine and donepezil in the treatment of moderate-to-severe Alzheimer's disease: An intent-to-treat analysis
by: Wilcock, G, et al.
Published: (2003)

A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.
by: Wilcock, G, et al.
Published: (2003)

The beneficial effects of galantamine on caregiver time in Alzheimer's disease
by: Sano, M, et al.
Published: (2003)

The effects of galantamine treatment on caregiver time in Alzheimer's disease.
by: Sano, M, et al.
Published: (2003)

Galantamine vs donepezil in the treatment of Alzheimer's disease.
by: Goldlist, B, et al.
Published: (2003)

Three-year follow-up of galantamine therapy for Alzheimer's disease: Efficacy and tolerability in open-label extension studies
by: Wilcock, G, et al.
Published: (2002)

Design and development of galantamine hydrobromide transdermal patch for treatment of alzheimer’s disease
by: Woo, Fong Yen
Published: (2015)

Effect of galantamine on time to residential or nursing home admission
by: Feldman, H, et al.
Published: (2004)

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
by: Wilcock, G, et al.
Published: (2008)

Long-term safety, tolerability and efficacy of galantamine: Results from a 36-month analysis of extension study data
by: Wilcock, G, et al.
Published: (2002)

Patterns of clinically detectable treatment effects with galantamine: a qualitative analysis.
by: Joffres, C, et al.
Published: (2003)

Formulation and evaluation of galantamine gel as drug reservoir in transdermal patch delivery system
by: Woo, Fong Yen, et al.
Published: (2015)

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials.
by: Whitehead, A, et al.
Published: (2004)

Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial.
by: Holgate, S, et al.
Published: (2011)

A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).
by: Wilcock, G, et al.
Published: (2002)

Lack of evidence for the efficacy of memantine in mild Alzheimer disease
by: Schneider, L, et al.
Published: (2011)

Lack of evidence for the efficacy of memantine in mild Alzheimer disease.
by: Schneider, L, et al.
Published: (2011)

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease.
by: Pratt, R, et al.
Published: (2001)

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease.
by: Perdomo, C, et al.
Published: (2003)

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease
by: Wilcock, G, et al.
Published: (2001)

Efficacy and tolerability of lercanidipine in mild to moderate hypertension among Asians of different ethnic groups
by: Chia, Yook Chin, et al.
Published: (2009)

Flurizan, (MPC-7869, (R)-flurbiprofen) a selective A beta-42 lowering agent in patients with mild to moderate Alzheimer's disease: A randomised, placebo-controlled, double blind trial
by: Wilcock, G, et al.
Published: (2005)

Whole-body hypothermia in mild neonatal encephalopathy: protocol for a multicentre phase III randomised controlled trial
by: Garegrat, R, et al.
Published: (2024)

Visual attention in ageing, mild cognitive impairment and Alzheimer's disease
by: Tales, A, et al.
Published: (2002)

Galanthamine hydrobromide: Interim results of a group comparative, placebo-controlled study of efficacy and safety in patients with a diagnosis of senile dementia of the Alzheimer type
by: Wilcock, G, et al.
Published: (1997)

The curious case of an internal pilot in a multicentre randomised trial-time for a rethink?
by: Cook, J, et al.
Published: (2016)

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
by: Datoo, MS, et al.
Published: (2024)

Abnormal visual search in mild cognitive impairment and Alzheimer's disease.
by: Tales, A, et al.
Published: (2005)

An evaluation of the efficacy and safety of tetrahydroaminoacridine (THA) without lecithin in the treatment of Alzheimer's disease.
by: Wilcock, G, et al.
Published: (1993)

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.
by: Jones, R, et al.
Published: (2009)

Efficacy and safety of MPC-7869 (R-flurbiprofen), a selective ab42-lowering agent, in mild Alzheimer's disease (AD): Results of a 12-month Phase 2 trial and 1-year follow-on study
by: Black, S, et al.
Published: (2006)

Safety and efficacy of diaphragm pacing in patients with respiratory insufficiency due to amyotrophic lateral sclerosis (DiPALS): a multicentre, open-label, randomised controlled trial
by: McDermott, C, et al.
Published: (2015)

A multicenter randomized controlled trial to evaluate the efficacy and safety of nelfinavir in patients with mild COVID-19
by: Miyazaki, T, et al.
Published: (2023)

Safety and efficacy of whole-body chlorhexidine gluconate cleansing with or without emollient in hospitalised neonates (NeoCHG): a multicentre, randomised, open-label, factorial pilot trial
by: Russell, N, et al.
Published: (2024)